Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022)
Weed (BUDZ) posted quarterly Net Equity Issued and Repurchased of $10000.0 for Q2 2022, down 94.12% year-over-year from $170000.0 in Q2 2021, and down 66.67% quarter-over-quarter from $30000.0 in Q1 2022.
Weed (BUDZ) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends
Weed's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $10000.0 for Q2 2022.
- In Q2 2022, Net Equity Issued and Repurchased fell 94.12% year-over-year to $10000.0; the TTM figure through Dec 2022 stood at $40000.0 (down 92.86% YoY), while the FY2022 annual figure was $40000.0, down 92.86% from the prior year.
- Net Equity Issued and Repurchased for Q2 2022 stood at $10000.0, down from $30000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $2.0 million in Q4 2018, with the low at $10000.0 in Q2 2022.
- The 5-year median for Net Equity Issued and Repurchased is $100000.0 (2020), against an average of $381847.1.
- The sharpest annual moves came in 2018 and 2019: Net Equity Issued and Repurchased jumped 1381.37% in 2018, then sank 96.25% in 2019.
- Weed's Net Equity Issued and Repurchased stood at $2.0 million in 2018, then tumbled by 96.25% to $74999.0 in 2019, then jumped by 33.34% to $100000.0 in 2020, then slipped by 20.0% to $80000.0 in 2021, then tumbled by 87.5% to $10000.0 in 2022.
- Business Quant data shows BUDZ's Net Equity Issued and Repurchased at $10000.0 in Q2 2022, $30000.0 in Q1 2022, and $80000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 170,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Mar 31, 2021 | 210,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 55,000.00 |
| Jun 30, 2020 | 55,000.00 |
| Mar 31, 2020 | 40,000.00 |
| Mar 31, 2020 | 40,000.00 |